(Q40776719)

English

TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

L F Lincz

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

T X Yeh

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

A Spencer

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1650-1657

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades. Nordic Myeloma Study Group (NMSG)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation in multiple myeloma: results of the European Group for Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

How TRAIL kills cancer cells, but not normal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

BCR-ABL-positive lymphoblastoid cells display limited proliferative capacity under in vitro culture conditions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402251

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402251

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40776719&oldid=2203971574"